| For: | Yoshikawa I, Nagato M, Yamasaki M, Kume K, Otsuki M. Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World J Gastroenterol 2009; 15(38): 4794-4798 [PMID: 19824113 DOI: 10.3748/wjg.15.4794] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i38/4794.htm |
| Number | Citing Articles |
| 1 |
Mesut Savas, Vincent L. Wester, Jenny A. Visser, Lotte Kleinendorst, Bert van der Zwaag, Mieke M. van Haelst, Erica L.T. van den Akker, Elisabeth F.C. van Rossum. Extensive Phenotyping for Potential Weight-Inducing Factors in an Outpatient Population with Obesity. Obesity Facts 2019; 12(4) doi: 10.1159/000499978
|
| 2 |
Peter Fentz Haastrup, Dorte Ejg Jarbøl, Wade Thompson, Jane Møller Hansen, Jens Søndergaard, Sanne Rasmussen. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterology 2021; 8(1) doi: 10.1136/bmjgast-2020-000563
|
| 3 |
Jessica A. Davis, Fiona Collier, Mohammadreza Mohebbi, Amanda L. Stuart, Amy Loughman, Julie A. Pasco, Felice N. Jacka. Obesity, Akkermansia muciniphila, and Proton Pump Inhibitors: Is there a Link?. Obesity Research & Clinical Practice 2020; 14(6) doi: 10.1016/j.orcp.2020.10.006
|
| 4 |
Jing Chen, Lihong Chen, Philippe Sanseau, Johannes M. Freudenberg, Deepak K. Rajpal. Significant obesity-associated gene expression changes occur in the stomach but not intestines in obese mice. Physiological Reports 2016; 4(10) doi: 10.14814/phy2.12793
|
| 5 |
Emily K. Ward, Elsbeth Jensen-Otsu, Jonathon A. Schoen, Kevin Rothchild, Breana Mitchell, Gregory L. Austin. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. Surgery for Obesity and Related Diseases 2015; 11(3) doi: 10.1016/j.soard.2014.09.027
|
| 6 |
Current Management of Obesity in an Infertile Female-Recent Advances and Future Prospective Drugs. Journal of Pharmacy and Nutrition Sciences 2013; 3(3) doi: 10.6000/1927-5951.2013.03.03.2
|
| 7 |
Eline S. van der Valk, Erica L.T. van den Akker, Mesut Savas, Lotte Kleinendorst, Jenny A. Visser, Mieke M. Van Haelst, Arya M. Sharma, Elisabeth F.C. van Rossum. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obesity Reviews 2019; 20(6) doi: 10.1111/obr.12836
|
| 8 |
Jinqiu Yuan, Qiangsheng He, Long H Nguyen, Martin C S Wong, Junjie Huang, Yuanyuan Yu, Bin Xia, Yan Tang, Yulong He, Changhua Zhang. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Gut 2021; 70(6) doi: 10.1136/gutjnl-2020-322557
|
| 9 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4) doi: 10.1111/1751-2980.13093
|
| 10 |
Jérémie Thereaux, Thomas Lesuffleur, Sébastien Czernichow, Arnaud Basdevant, Simon Msika, David Nocca, Bertrand Millat, Anne Fagot-Campagna. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surgery for Obesity and Related Diseases 2017; 13(6) doi: 10.1016/j.soard.2016.12.013
|
| 11 |
Ufuk Kutluana. The effect of long-term proton pump inhibitor use on the visceral adiposity index. Marmara Medical Journal 2025; 38(3) doi: 10.5472/marumj.1800011
|
| 12 |
Chih-Chia Liang, I.-Kuan Wang, Hsin-Hung Lin, Hung-Chieh Yeh, Jiung-Hsiun Liu, Huey-Liang Kuo, Wei-Min Hsu, Chiu-Ching Huang, Chiz-Tzung Chang. Prophylactic Use of Omeprazole Associated with a Reduced Risk of Peptic Ulcer Disease Among Maintenance Hemodialysis Patients. Renal Failure 2011; 33(3) doi: 10.3109/0886022X.2011.560407
|
| 13 |
Janaina Luz Narciso-Schiavon, Leonardo Lucca Schiavon. Fatty liver and celiac disease: Why worry?. World Journal of Hepatology 2023; 15(5): 666-674 doi: 10.4254/wjh.v15.i5.666
|
| 14 |
Yu-Fong Syu, Hsien-Hao Huang, Chih-Yen Chen. Do Proton Pump Inhibitors Contribute to Weight Gain?. Obesity Surgery 2015; 25(6) doi: 10.1007/s11695-015-1659-x
|
| 15 |
Itay Amir, Fred M. Konikoff, Michal Oppenheim, Uri Gophna, Elizabeth E. Half. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environmental Microbiology 2014; 16(9) doi: 10.1111/1462-2920.12285
|
| 16 |
Katharina Schnabl, Yongguo Li, Martin Klingenspor. The gut hormone secretin triggers a gut–brown fat–brain axis in the control of food intake. Experimental Physiology 2020; 105(8) doi: 10.1113/EP087878
|
| 17 |
Jonathan R. Zadeh, Rafael Alvarez, Leena Khaitan, Mujjahid Abbas. Conversion of gastric sleeve to Roux-en-Y gastric bypass: overall outcomes and predictors of below-average weight loss. Surgery for Obesity and Related Diseases 2023; 19(2) doi: 10.1016/j.soard.2022.10.029
|
| 18 |
Mubin I. Syed, Kamal Morar, Azim Shaikh, Paul Craig, Omar Khan, Sumeet Patel, Hooman Khabiri. Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data. Journal of Vascular and Interventional Radiology 2016; 27(10) doi: 10.1016/j.jvir.2016.07.010
|
| 19 |
Milena Saqui-Salces, Amy C. Tsao, Merritt G. Gillilland, Juanita L. Merchant. Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(1) doi: 10.1152/ajpgi.00211.2016
|
| 20 |
Emily K. Ward, Dara P. Schuster, Katie H. Stowers, Amanda K. Royse, Diana Ir, Charles E. Robertson, Daniel N. Frank, Gregory L. Austin. The Effect of PPI Use on Human Gut Microbiota and Weight Loss in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass. Obesity Surgery 2014; 24(9) doi: 10.1007/s11695-014-1275-1
|
| 21 |
Hsien-Hao Huang, Harn-Shen Chen, Chih-Yen Chen. Association of short-term proton pump inhibitor therapy with weight gain in patients older than 40 years with gastric ulcer. Surgery for Obesity and Related Diseases 2015; 11(5) doi: 10.1016/j.soard.2015.05.013
|
| 22 |
Nicola Imperatore, Raffaella Tortora, Anna Testa, Nicolò Gerbino, Nicola Caporaso, Antonio Rispo. Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet. Journal of Gastroenterology 2018; 53(4) doi: 10.1007/s00535-017-1381-7
|
| 23 |
Wei-Sheng Lin, Cheng-Wen Huang, You-Sheng Song, Jui-Hung Yen, Ping-Chang Kuo, Sheng-Rong Yeh, Hung-Yu Lin, Tsai-Feng Fu, Ming-Shiang Wu, Horng-Dar Wang, Pei-Yu Wang, Chih-Pin Chuu. Reduced Gut Acidity Induces an Obese-Like Phenotype in Drosophila melanogaster and in Mice. PLOS ONE 2015; 10(10) doi: 10.1371/journal.pone.0139722
|
| 24 |
Jennifer Czwornog, Gregory Austin. Association of Proton Pump Inhibitor (PPI) Use with Energy Intake, Physical Activity, and Weight Gain. Nutrients 2015; 7(10) doi: 10.3390/nu7105416
|
| 25 |
C Menni, M A Jackson, T Pallister, C J Steves, T D Spector, A M Valdes. Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain. International Journal of Obesity 2017; 41(7) doi: 10.1038/ijo.2017.66
|
| 26 |
Jose D Sollano, Rommel P Romano, Leticia Ibañez-Guzman, Marie Antoinette DC Lontok, Sherrie Q de Ocampo, Allan A Policarpio, Roberto N de Guzman, Carmelita D Dalupang, Augusto Jose G Galang, Ernesto G Olympia, Maria Anna L Chua, Bernadette A Moscoso, Jose A Tan, John Arnel N Pangilinan, Arnold O Vitug, Marichona C Naval, Danilo A Encarnacion, Peter P Sy, Evan G Ong, Oscar T Cabahug, Maria Lourdes O Daez, Albert E Ismael, Joseph C Bocobo. Clinical Practice Guidelines on the Diagnosis and Treatment of Gastroesophageal Reflux Disease (GERD). Philippine Journal of Internal Medicine 2015; 53(3) doi: 10.65564/pjim.9662862c41
|